CALC
Price
$3.24
Change
+$0.14 (+4.52%)
Updated
Sep 3, 04:59 PM (EDT)
Capitalization
44.99M
PCSA
Price
$0.19
Change
-$0.00 (-0.00%)
Updated
Sep 3 closing price
Capitalization
9.45M
Interact to see
Advertisement

CALC vs PCSA

Header iconCALC vs PCSA Comparison
Open Charts CALC vs PCSABanner chart's image
CalciMedica
Price$3.24
Change+$0.14 (+4.52%)
Volume$500
Capitalization44.99M
Processa Pharmaceuticals
Price$0.19
Change-$0.00 (-0.00%)
Volume$2.09M
Capitalization9.45M
CALC vs PCSA Comparison Chart in %
Loading...
CALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CALC vs. PCSA commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CALC is a Buy and PCSA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (CALC: $3.10 vs. PCSA: $0.19)
Brand notoriety: CALC and PCSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CALC: 491% vs. PCSA: 21%
Market capitalization -- CALC: $44.99M vs. PCSA: $9.45M
CALC [@Biotechnology] is valued at $44.99M. PCSA’s [@Biotechnology] market capitalization is $9.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CALC’s FA Score shows that 1 FA rating(s) are green whilePCSA’s FA Score has 1 green FA rating(s).

  • CALC’s FA Score: 1 green, 4 red.
  • PCSA’s FA Score: 1 green, 4 red.
According to our system of comparison, CALC is a better buy in the long-term than PCSA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CALC’s TA Score shows that 4 TA indicator(s) are bullish while PCSA’s TA Score has 3 bullish TA indicator(s).

  • CALC’s TA Score: 4 bullish, 4 bearish.
  • PCSA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CALC is a better buy in the short-term than PCSA.

Price Growth

CALC (@Biotechnology) experienced а +8.01% price change this week, while PCSA (@Biotechnology) price change was -15.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CALC($45M) has a higher market cap than PCSA($9.45M). CALC YTD gains are higher at: -12.429 vs. PCSA (-78.717). PCSA has higher annual earnings (EBITDA): -12.96M vs. CALC (-30.55M). CALC has more cash in the bank: 18M vs. PCSA (6.94M). PCSA has less debt than CALC: PCSA (25.6K) vs CALC (8.5M). CALC (0) and PCSA (0) have equivalent revenues.
CALCPCSACALC / PCSA
Capitalization45M9.45M476%
EBITDA-30.55M-12.96M236%
Gain YTD-12.429-78.71716%
P/E Ratio0.30N/A-
Revenue00-
Total Cash18M6.94M259%
Total Debt8.5M25.6K33,203%
TECHNICAL ANALYSIS
Technical Analysis
CALCPCSA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 9 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CALC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLOV2.690.07
+2.67%
Clover Health Investments Corp
QETA11.19N/A
N/A
Quetta Acquisition Corp
AXP331.18-0.10
-0.03%
American Express Company
WH86.35-0.26
-0.30%
Wyndham Hotels & Resorts
CTRN35.02-0.61
-1.71%
Citi Trends

CALC and

Correlation & Price change

A.I.dvisor tells us that CALC and PRRUF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CALC and PRRUF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CALC
1D Price
Change %
CALC100%
+14.81%
PRRUF - CALC
26%
Poorly correlated
N/A
CNSP - CALC
25%
Poorly correlated
+0.81%
ABOS - CALC
23%
Poorly correlated
N/A
PCSA - CALC
22%
Poorly correlated
-0.48%
ORMP - CALC
22%
Poorly correlated
-2.27%
More

PCSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCSA has been loosely correlated with OPORF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PCSA jumps, then OPORF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCSA
1D Price
Change %
PCSA100%
-0.48%
OPORF - PCSA
51%
Loosely correlated
N/A
INO - PCSA
38%
Loosely correlated
+8.44%
ONCO - PCSA
34%
Loosely correlated
N/A
MGX - PCSA
30%
Poorly correlated
+4.60%
LVTX - PCSA
27%
Poorly correlated
-0.64%
More